Skip to main content

Table 1 Colorectal cancer cell lines used for the study

From: Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells

CRC cell line

Caco-2/15

DLD-1

HCT-116

HT-29

SW480

SW620

TNM stage

?

III

?

II/III

II

III

Genetic profile

 CIN

+

–

–

+

+

+

 MSI

–

+

+

–

–

–

 CIMP

–

+

+

+

–

–

CMS and proteomic subtypes

 CMS subtype

2

N/A

1

3

N/A

N/A

 Proteomic subtype

A

B

B

D

E

B

Mutations

 KRAS

–

G13D

G13D

–

G12V

G12V

 BRAF

–

–

–

V600E

–

–

 PIK3CA

–

E545K; D549N

H1047R

P449T

–

–

 TP53

E204X

S241F

–

R273H

R273H; P309S

R273H; P309S

Radio- and chemo-sensitivities

 Radio-sensitivity (LD50)

4.3 Gy

2.9 Gy

1.7 Gy

4.6 Gy

2.4 Gy

2.7 Gy

 5-FU-sensitivity (IC50)

2.1 μM

9.3 μM

4.5 μM

2.7 μM

2.4 μM

6.7 μM

  1. The table lists the TNM stages of the patients which these lines come from. Genetic profiles CIN, MSI and CIMP are indicated (+) as well as the CMS and proteomic subtypes [2, 57, 58], the associated mutations [59,60,61,62,63] and the LD50 and IC50 previously measured (Fig. 1, Fig. S1). TNM tumor, nodes, metastasis, CIN chromosomal instability, MSI microsatellite instability, CIMP CpG island methylator phenotype, CMS consensus molecular subtype, KRAS V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, BRAF v-Raf murine sarcoma viral oncogene homolog B1, PIK3CA phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, TP53 cellular tumor antigen p53